Brain β-Amyloid Accumulation in Transgenic Mice Expressing Mutant Superoxide Dismutase 1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neurochemical Research

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11064-004-7037-zPMID 15672551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice

  2004cited by this paper
• Functional and morphological alterations in compound transgenic mice overexpreszing Cu/Zn superoxide dismutaze and amyloid precursor protein

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction].

  2004cited by this paper
• Alzheimer disease pathology in amyotrophic lateral sclerosis

  2004cited by this paper
• Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators.

  2004cited by this paper
• Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses.

  2003cited by this paper
• Immunohistochemical study on the aggregation of ubiquitin in the central nervous system of the transgenic mice expressing a human Cu/Zn SOD mutation

  2003cited by this paper
• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis.

  2003cited by this paper
• Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation.

  2003cited by this paper
• Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine.

  2002cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Alterations in vascular reactivity in single- and double-transgenic mice coexpressing human APP-C100 and mutant SOD(1) genes.

  2002cited by this paper
• Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site.

  2002cited by this paper
• Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.

  2002cited by this paper
• A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis.

  2001cited by this paper
• Alzheimer's disease and Abeta toxicity: from top to bottom.

  2001cited by this paper
• Learning about the context in genetically-defined mice.

  2001cited by this paper
• Alzheimer's disease and Aβ toxicity: from top to bottom

  2001cited by this paper
• Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus.

  2000cited by this paper
• Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

  2000cited by this paper
• Survival of motor neurons and expression of β‐amyloid protein in the aged rat spinal cord

  2000cited by this paper
• Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures.

  2000cited by this paper
• Substrate‐Bound β‐Amyloid Peptides Inhibit Cell Adhesion and Neurite Outgrowth in Primary Neuronal Cultures

  2000cited by this paper
• Brain Accumulation of Amyloid-beta in Non-Alzheimer Neurodegeneration.

  1999cited by this paper
• Brain Accumulation of Amyloid-β in Non-Alzheimer Neurodegeneration

  1999cited by this paper
• SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

  1999cited by this paper
• Relationship of oxygen radical‐induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS

  1998cited by this paper
• Protein Oxidative Damage in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

  1998cited by this paper
• Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation

  1997cited by this paper
• Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis

  1996cited by this paper
• Increased antioxidant enzyme activity in amyloid beta protein-resistant cells

  1996cited by this paper
• Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells.

  1995cited by this paper
• Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.

  1994cited by this paper
• Alzheimer A beta amyloid forms an inhibitory neuronal substrate.

  1994cited by this paper
• Alzheimer Aβ Amyloid Forms an Inhibitory Neuronal Substrate

  1994cited by this paper
• βAPP Gene Expression is Increased in the Rat Brain After Motor Neuron Axotomy

  1993cited by this paper
• In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.

  1991cited by this paper
• In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity ☆

  1991cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper

• The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the 682YENPTY687 motif

  2023cites this paper
• Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  2023cites this paper
• Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells.

  2022cites this paper
• Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.

  2022cites this paper
• Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic

  2020cites this paper
• Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases

  2016cites this paper
• Oxidative Stress and Memory Decline in Adults with Down Syndrome: Longitudinal Study

  2012cites this paper
• eIF4A Inhibition Allows Translational Regulation of mRNAs Encoding Proteins Involved in Alzheimer's Disease

  2010cites this paper
• A possible physiological role of Abeta as a crosslinker

  2008cites this paper
• Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice.

  2008cites this paper
• COMPARISON OF RILUZOLE WITH N-ACETYLCYSTEINE AND VITAMIN E AGAINST H 2 O 2 - AND GLUTAMATE-INDUCED CYTOTOXICITY IN A MOTOR NEURON CELL LINE

  2007cites this paper
• Overexpression of Aβ is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model

  2006cites this paper
• Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement.

  2006cites this paper
• Oxidative stress in Alzheimer's disease.

  2006cites this paper